Prolonged expression or activation of YAP in the liver promotes the emergence of tumoral lesions with features of either hepatocellular carcinoma or cholangiocarcinomas, thus demonstrating the oncogenic potential of YAP (8,9,11–15). This evidence concerns the gene YAP1 and cholangiocarcinoma.